Progranulin (GP88) is an independent prognostic factor for prostate cancer patients

被引：0
|
作者：
Taubert, Helge W. [1 ]
Abdulrahman, Amer [1 ]
Eckstein, Markus [1 ]
Jung, Rudolf [1 ]
Guzman, Juan [1 ]
Weigelt, Katrin [1 ]
Serrero, Ginette [2 ]
Yue, Binbin [2 ]
Geppert, Carol [1 ]
Stoehr, Robert [1 ]
Hartmann, Arndt [1 ]
Wullich, Bernd [1 ]
Wach, Sven [1 ]
机构：
[1] Univ Erlangen Nurnberg, Erlangen, Germany
[2] A&G Pharma, Columbia, MD USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4327
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Association between Progranulin (GP88) Expression and Recurrence Risk for Breast Cancer Patients with Estrogen Receptor Positive Invasive Ductal Carcinoma.
    Serrero, G.
    Hawkins, D. M.
    Ioffe, O.
    Bejarano, P.
    Phillips, J. T.
    Head, J. F.
    Elliott, R. L.
    Godwin, A. K.
    Weaver, J.
    Yue, B.
    CANCER RESEARCH, 2011, 71
  • [32] Correlation between expression of the prognostic marker Progranulin (GP88) with Oncotype Dx Recurrence Score in estrogen receptor positive breast tumors
    Serrero, G.
    Koka, M.
    Goicochea, L.
    Tkaczuk, K. R.
    Fernandez, K. L.
    Logan, L. S.
    Tuttle, K.
    Yue, B.
    Loffe, O. B.
    CANCER RESEARCH, 2012, 72
  • [33] GP88 Serum Level Is Increased in Breast Cancer Patients with Disease Progression
    Serrero, G.
    Tkaczuk, K.
    Yue, B.
    Kamimura, S.
    Tait, N.
    Zhan, M.
    Ecklund, D.
    CANCER RESEARCH, 2009, 69 (24) : 836S - 836S
  • [34] GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells
    Abrhale, Tesfom
    Brodie, Angela
    Sabnis, Gauri
    Macedo, Luciana
    Tian, Changsheng
    Yue, Binbin
    Serrero, Ginette
    BMC CANCER, 2011, 11
  • [35] Progranulin/GP88, A Complex and Multifaceted Player of Tumor Growth by Direct Action and via the Tumor Microenvironment
    Serrero, Ginette
    TUMOR MICROENVIRONMENT: NOVEL CONCEPTS, 2021, 1329 : 475 - 498
  • [36] Anti-Progranulin (GP88) antibody AG01 therapeutic effect in triple negative breast cancer invasiveness
    Guha, Rupa
    Dong, Jianping
    Yue, Binbin
    Serrero, Ginette
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Anti-progranulin (GP88) antibody AG01 inhibitory effect on the growth of triple negative breast cancer cells
    Serrero, Ginette
    Guha, Rupa
    Dong, Jianping
    Yue, Binbin
    CANCER RESEARCH, 2022, 82 (04)
  • [38] PC-cell derived growth factor (PCDGF/GP88, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
    Abrhale, T.
    Brodie, A.
    Serrero, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S9 - S9
  • [39] Treatment with anti-human GP88/progranulin antibody restores tamoxifen sensitivity to tamoxifen-resistant breast cancer cells
    Serrero, Ginette
    Dong, Jianping
    Yue, Binbin
    Hicks, David
    Hayashi, Jun
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [40] Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration
    Guha, Rupa
    Yue, Binbin
    Dong, Jianping
    Banerjee, Aditi
    Serrero, Ginette
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 637 - 653
12345